BR Biopharma, Inc. (NASDAQ:BRBI) Sees Large Growth in Short Interest

Posted by Geri Gentry on Nov 11th, 2026

BR Biopharma, Inc. (NASDAQ:BRBI – Get Free Report) saw a large growth in short interest in October. As of October 30th, there was short interest totaling 13,657 shares, a growth of 1,264.3% from the October 15th total of 1,001 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average trading volume of 6,646 shares, the days-to-cover ratio is presently 2.1 days.

Analyst Ratings Changes

BRBI has been the topic of several analyst reports. Citigroup downgraded shares of BR Biopharma from a “buy” rating to a “hold” rating in a report on Tuesday, October 27th. Weiss Ratings raised shares of BR Biopharma from a “sell (d-)” rating to a “sell (d)” rating in a research note on Friday, October 2nd. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Reduce”.

Read Our Latest Stock Analysis on BR Biopharma

BR Biopharma Stock Up 4.2%

Shares of BRBI stock opened at $7.62 on Wednesday. The company’s fifty day simple moving average is $11.43 and its two-hundred day simple moving average is $12.52. BR Biopharma has a 52 week low of $6.87 and a 52 week high of $16.61. The stock has a market cap of $89.99 million, a P/E ratio of 95.25 and a beta of 0.43.

BR Biopharma (NASDAQ:BRBI – Get Free Report) last issued its quarterly earnings data on Tuesday, November 3rd. The company reported $0.05 earnings per share for the quarter. The firm had revenue of $23.80 million for the quarter.

BR Biopharma Cuts Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 4th. Stockholders of record on Monday, November 16th will be issued a $0.0879 dividend. This is a negative change from BR Biopharma’s previous quarterly dividend of $0.1415. The ex-dividend date is Monday, November 16th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 4.6%. BR Biopharma’s dividend payout ratio (DPR) is presently 525.00%.

About BR Biopharma

(Get Free Report)

BRBI BR Partners S.A., through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners S.A. is based in S?o Paulo, Brazil.